BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22321427)

  • 41. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced Efficacy of Dust Mite Sublingual Immunotherapy in Low-Response Allergic Rhinitis Patients after Dose Increment at 6 Months: A Prospective Study.
    Gao Y; Lin X; Ma J; Wei X; Wang Q; Wang M
    Int Arch Allergy Immunol; 2020; 181(4):311-319. PubMed ID: 32069460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
    Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
    Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Efficacy of sublingual immunotherapy with Dermatophagoides farinae drops on patients with allergic rhinitis of different symptom severity].
    Hu X; Liu J; Fu S; Wei Y; Hu W; Liu Y; You J; Zhang M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Feb; 29(3):223-5. PubMed ID: 26012292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
    Compalati E; Passalacqua G; Bonini M; Canonica GW
    Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fast onset of action of sublingual immunotherapy in dust mite caused allergic rhinoconjunctivitis].
    Huang Z; Liu Y; Luo H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jun; 27(11):579-81. PubMed ID: 23987005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The mechanism and onset time of single dermatophagoides farina sublingual immunotherapy in patients with allergic rhinitis sensitized to dermatophagoides farina and dermatophagoides pteronyssinus].
    Tan H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(5):296-9. PubMed ID: 25185280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
    Mungan D; Misirligil Z; Gürbüz L
    Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of house dust mite sublingual immunotherapy in children with allergic rhinitis and asthma].
    Chen S; Zeng X; Wang L; Chen B; Chen L; Wu S; Liao F; Feng X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):627-31. PubMed ID: 26696198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term efficacy of sublingual immunotherapy with Dermatophagoides Farianae Drops in children with allergic asthma sensitized to dust mites].
    Tian M; Lu YQ; Wang Y; Jiang YH; Zhao DY
    Zhonghua Er Ke Za Zhi; 2013 Oct; 51(10):741-4. PubMed ID: 24406225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
    La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy and safety analysis with standardized mite allergen subcutaneous immunotherapy in 90 patients with allergic rhinitis].
    Li L; Guan GM; Zhu DD; Sha JC; Jin GH; Chen MX; Zhang H; Dong Z
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):445-8. PubMed ID: 22932133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
    Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
    J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
    Riechelmann H; Schmutzhard J; van der Werf JF; Distler A; Kleinjans HA
    Am J Rhinol Allergy; 2010; 24(5):e104-9. PubMed ID: 21244725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.